BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2008
View Archived Issues
Y's Therapeutics and Kissei sign Japanese licensing agreement for YSCMA
Read More
XenoPort to initiate a phase II clinical trial of XP1-9986 in acute back spasms
Read More
Tuberculosis vaccine VPM-1002 enters phase I investigation
Read More
Beneficial effects seen with ivabradine in some coronary artery disease patients
Read More
FDA releases clinical hold on Novacea's Asentar IND application
Read More
CuraGen completes enrollment in phase II CR011-vcMMAE trial in melanoma
Read More
FDA places partial clinical hold on phase III GVAX program in prostate cancer
Read More
Final patient completes first phase III sodium oxybate trial in fibromyalgia
Read More
Inspire plans clinical testing of new glaucoma compound INS-117548
Read More
MAT completes enrollment in phase I/II Ferritarg trial in Hodgkin's disease
Read More
Phase II results for brivanib alaninate disclosed at the ILCA Conference
Read More
TAC-101 provides disease stabilization and prolonged survival in advanced HCC phase I/II study
Read More
Novel natural compound prevents bone loss in experimental model of osteoporosis
Read More
MedImmune enters autoimmune disease research collaboration with SBI Biotech
Read More
Positive results in aromatase-resistant breast cancer with combined sorafenib/anastrozole therapy
Read More
Oxygen sets FDA meeting date for proposed phase IIb Oxycyte trial
Read More
FDA approves Gamunex for inflammatory demyelinating polyneuropathy
Read More
Novel treatment options for obesity described in recent patents
Read More
AstraZeneca and Targacept report results from phase IIb AZD-3480 trial
Read More
New compounds for treating glaucoma disclosed in recent Allergan patent
Read More
Enanta initiates phase Ia study for oral antibiotic EDP-322
Read More
University of Southern California patent claims novel agents for osteoporosis
Read More
Othera commences phase I/II OT-730 trial in ocular hypertension and glaucoma
Read More
Phase II study evaluates Exinalda in CF patients with fat malabsorption
Read More
Xarelto approved in Canada for prevention of venous thromboembolic events
Read More